tradingkey.logo
tradingkey.logo
Pesquisar

Bioventus Inc

BVS
Adicionar à lista de desejos
10.480USD
+0.630+6.40%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
703.18MValor de mercado
24.52P/L TTM

Mais detalhes de Bioventus Inc Empresa

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Informações de Bioventus Inc

Código da empresaBVS
Nome da EmpresaBioventus Inc
Data de listagemFeb 11, 2021
CEOClaypoole (Robert E)
Número de funcionários930
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 11
Endereço4721 Emperor Boulevard, Suite 100
CidadeDURHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27703
Telefone19194746700
Sitehttps://www.bioventus.com/
Código da empresaBVS
Data de listagemFeb 11, 2021
CEOClaypoole (Robert E)

Executivos da empresa Bioventus Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
138.24K
+23.35%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
117.52K
+27.47%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
111.90K
+28.85%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
108.72K
+29.69%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
32.28K
--
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
138.24K
+23.35%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
117.52K
+27.47%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
111.90K
+28.85%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
108.72K
+29.69%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
32.28K
--
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Bioventus Inc?

Os cinco principais acionistas de Bioventus Inc são: Ms. Susan M. Stalnecker

Quantas instituições possuem ações da Bioventus Inc (BVS)?

Em 2026Q1, 339 instituições possuíam ações da Bioventus Inc, com valor de mercado aproximado de 52.51M, representando 77.51% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -10203484.00.

Qual é a maior fonte de receita da Bioventus Inc?

Em 2026Q1, o segmento de negócios Pain Treatments gerou a maior receita para Bioventus Inc, totalizando 279.06M e representando 49.12% da receita total.